FRET-labeled compounds and uses therefor

• US 10,066,258 B2
• Filed: 12/14/2016
• Issued: 09/04/2018
• Est. Priority Date: 03/30/2009
• Status: Active Grant

• Current Assignee: Pacific Bioscience of California Incorporated (L'Oreal SA)
• Original Assignee: Pacific Bioscience of California Incorporated (L'Oreal SA)
• Inventors: Kong, Xiangxu, Shen, Gene
• Primary Examiner(s): Riley, Jezia
• Application Number:
  US15/379,118
• Publication Number:
  US 20170159111A1
• Time in Patent Office: 629 Days
• Field of Search: 435 61, 435 612, 435 911
• CPC Class Codes: C07H 19/207 the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
• CPC Class Codes: C12Q 1/6818 involving interaction of two or more labels, e.g. resonant energy transfer
• CPC Class Codes: C12Q 1/6869 Methods for sequencing
• CPC Class Codes: G01N 2021/6441 with two or more labels
• CPC Class Codes: G01N 21/6428 Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" in vivo A61B5/00; immunoassay G01N33/53
• CPC Class Codes: G01N 33/542 with steric inhibition or signal modification, e.g. fluorescent quenching
• CPC Class Codes: G01N 33/582 with fluorescent label
• CPC Class Codes: Y10T 436/143333 Saccharide [e.g., DNA, etc.]

Abstract

FRET-labeled compounds are provided for use in analytical reactions. In certain embodiments, FRET-labeled nucleotide analogs are used in place of naturally occurring nucleoside triphosphates or other analogs in analytical reactions comprising nucleic acids, for example, template-directed nucleic acid synthesis, DNA sequencing, RNA sequencing, single-base identification, hybridization, binding assays, and other analytical reactions.

Claims

1. A method of performing nucleic acid sequence analysis, comprising:

providing an optical confinement comprising a complex comprising a template nucleic acid and a polymerase enzyme, wherein the complex is capable of template-dependent synthesis of a complementary nascent nucleic acid strand;

contacting the complex with a reaction mixture to synthesize a nascent nucleic acid strand complementary to the template nucleic acid, wherein the reaction mixture comprises first and second nucleotide analogs, wherein the first nucleotide analog comprises a first fluorescent label that produces a first signal in response to excitation illumination, and the second nucleotide analog comprises a second fluorescent label that produces a second signal in response to excitation illumination, wherein the first and second signals have distinct signal intensities, and wherein the first and second signals comprise peaks at the same wavelengths;

illuminating the optical confinement with excitation illumination for the first and second fluorescent labels;

monitoring the illuminated optical confinement to detect signals produced for a plurality of incorporation events in real time during template-dependent synthesis of the nascent nucleic acid strand complementary to the template nucleic acid, wherein the first signal is detectable during incorporation of the first nucleotide analog into the complementary nascent nucleic acid strand and the second signal is detectable during incorporation of the second nucleotide analog into the complementary nascent nucleic acid strand, wherein during incorporation of the first or second nucleotide analogs the first or second fluorescent labels are removed;

identifying a detected signal as a first signal or a second signal based upon its signal intensity; and

correlating the identified first or second signal to the incorporation of the first or second nucleotide analog into the nascent nucleic acid strand, respectively.

2. The method of claim 1, further comprising identifying a base in the template nucleic acid as complementary to the incorporated first or second nucleotide.

3. The method of claim 1, wherein the optical confinement comprises a single complex.

4. The method of claim 1, wherein the polymerase enzyme is immobilized within the optical confinement.

5. The method of claim 1, wherein the optical confinement is present on a solid support.

6. The method of claim 1, wherein the solid support comprises an array of multiple optically resolvable optical confinements.

7. The method of claim 6, wherein the multiple optically resolvable optical confinements of the array are monitored simultaneously to perform multiple nucleic acid sequence analyses.

8. The method of claim 7, wherein each of the multiple optical confinements of the array are illuminated by a waveguide array.

9. The method of claim 1, wherein the optical confinement comprises a zero-mode waveguide.

10. The method of claim 1, wherein the optical confinement comprises a nanohole.

11. The method of claim 1, wherein at least one of the first and second signals comprises distinct emission signal intensities at a plurality of different wavelengths.

12. The method of claim 1, wherein the first fluorescent label comprises a first FRET label having a first FRET efficiency, and the second fluorescent label comprises a second FRET label having a second FRET efficiency different from the first FRET efficiency, wherein the first FRET label and the second FRET label each comprise at least two chromophores that engage in FRET.

13. The method of claim 12, wherein the first and second FRET efficiencies are from about 0 to about 100% of a maximum FRET efficiency for each of the first and second FRET labels.

14. The method of claim 1, wherein the reaction mixture comprises at least a third nucleotide analog, the third nucleotide analog comprising a third fluorescent label producing a third signal in response to excitation illumination, the third signal differing from each of the first and second signals by at least one of its emission intensity and its emission spectrum.

15. The method of claim 14, wherein the reaction mixture comprises at least a fourth nucleotide analog, the fourth reactant comprising a fourth fluorescent label producing a fourth signal in response to excitation illumination, the fourth signal differing from each of the first, second and third signals by at least one of its emission intensity and its emission spectrum.

16. The method of claim 1, wherein said reaction mixture further comprises two additional nucleotide analogs, wherein at least one of the first, second, and additional nucleotide analogs comprises a FRET label and one other comprises a non-FRET label.

17. The method of claim 1, wherein the first and second reactants comprise FRET labels having the same constituent FRET label moieties in different orientations.

18. The method of claim 1, wherein the reaction mixture further comprises nucleotide analogs having multiple labeling moieties that do not undergo FRET.